(Q38218439)

31 August 2017

title

HDL and cholesterol handling in the brain (English)

1 reference

31 August 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907980%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Cecilia Vitali

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907980%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Cheryl L Wellington

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907980%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

6 June 2014

1 reference

31 August 2017

published in

Cardiovascular Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907980%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907980%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907980%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

405-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24907980%20AND%20SRC:MED&resulttype=core&format=json

Central nervous system: cholesterol turnover, brain development and neurodegeneration

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Lipid metabolism and glial lipoproteins in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Brain cholesterol: long secret life behind a barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

The blood-brain barrier in health and chronic neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Oxysterols and neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Severe learning deficits in apolipoprotein E-knockout mice in a water maze task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Formation and function of apolipoprotein E-containing lipoproteins in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Apolipoprotein E in Alzheimer's disease and other neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Clusterin/apolipoprotein J in human aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Lifelong expression of apolipoprotein D in the human brainstem: correlation with reduced age-related neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Lipoproteins in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Role of ATP-binding cassette transporters in brain lipid transport and neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

ABCA8 stimulates sphingomyelin production in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Cholesteryl ester transfer protein in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

No association of CETP genotype with cognitive function or age-related cognitive change

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Unique lipoprotein phenotype and genotype associated with exceptional longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Phospholipid transfer protein (PLTP) deficiency impaired blood-brain barrier integrity by increasing cerebrovascular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Cholesterol metabolism in neurons and astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Low density lipoprotein receptor-related protein 1 (LRP1) modulates N-methyl-D-aspartate (NMDA) receptor-dependent intracellular signaling and NMDA-induced regulation of postsynaptic protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Abnormal positioning of granule cells alters afferent fiber distribution in the mouse fascia dentata: morphologic evidence from reeler, apolipoprotein E receptor 2-, and very low density lipoprotein receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Mutations in the very low-density lipoprotein receptor VLDLR cause cerebellar hypoplasia and quadrupedal locomotion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Association between high-density lipoprotein and cognitive impairment in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

High-density lipoprotein cholesterol in differential diagnosis of senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Antiinflammatory properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Endothelial protection by high-density lipoproteins: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Paraoxonase 1 activity in different types of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Low HDL cholesterol associates with major depression in a sample with a 7-year history of depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Mendelian disorders of high-density lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

The effects of altered apolipoprotein A-I structure on plasma HDL concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Structure, function and amyloidogenic propensity of apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

ABC1: connecting yellow tonsils, neuropathy, and very low HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Recent insights into the Smith-Lemli-Opitz syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Review: sporadic cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Huntington's disease and Huntington's disease-like syndromes: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Mechanisms of neurodegeneration in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Whole body cholesterol metabolism is impaired in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Advances in the genetics of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Glucocerebrosidase mutations and the pathogenesis of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Lipid dysfunction and pathogenesis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Tricarboxylic acid cycle-sustained oxidative phosphorylation in isolated myelin vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Widespread alterations of alpha-synuclein in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148

Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVU148